Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine
  2. Marin, Alexander; Chowdhury, Ananda; Valencia, Sarah M.; Zacharia, Athina; Kirnbauer, Reinhard; Roden, Richard B. S.; Pinto,Ligia; Shoemaker, Robert H.; Marshall,Jason; Andrianov, Alexander K.
  3. Nanomedicine : Nanotechnology, Biology, and Medicine. 2021, Apr 1; 33
  1. 2.   Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles
  2. Tarasov, S. G.; Gaponenko, V.; Howard, O. M. Z.; Chen, Y. H.; Oppenheim, J. J.; Dyba, M. A.; Subramaniam, S.; Lee, Y.; Michejda, C.; Tarasova, N. I.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jun; 108(24): 9798-9803.
  1. 3.   Materials from peptide assembly: towards the treatment of cancer and transmittable disease
  2. Branco, M. C.; Sigano, D. M.; Schneider, J. P.
  3. Current Opinion in Chemical Biology. 2011, Jun; 15(3): 427-434.
  1. 4.   HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
  2. Kemp, T. J.; Hildesheim, A.; Safaeian, M.; Dauner, J. G.; Pan, Y. J.; Porras, C.; Schiller, J. T.; Lowy, D. R.; Herrero, R.; Pinto, L. A.
  3. Vaccine. 2011, Mar; 29(11): 2011-2014.
  1. 5.   BUD22 Affects Ty1 Retrotransposition and Ribosome Biogenesis in Saccharomyces cerevisiae
  2. Dakshinamurthy, A.; Nyswaner, K. M.; Farabaugh, P. J.; Garfinkel, D. J.
  3. Genetics. 2010, Aug; 185(4): 1193-U99.
  1. 6.   Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
  2. Dauner, J. G.; Pan, Y. J.; Hildesheim, A.; Harro, C.; Pinto, L. A.
  3. Vaccine. 2010, Jul; 28(33): 5407-5413.
  1. 8.   Posttranslational interference of Ty1 retrotransposition by antisense RNAs
  2. Matsuda, E.; Garfinkel, D. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(37): 15657-15662.
  1. 9.   Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies
  2. Kemp, T. J.; Hildesheim, A.; Falk, R. T.; Schiller, J. T.; Lowy, D. R.; Rodriguez, A. C.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2008 15(1): 60-64.
  1. 10.   Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents
  2. Warfield, K. L.; Posten, N. A.; Swenson, D. L.; Olinger, G. G.; Esposito, D.; Gillette, W. K.; Hopkins, R. F.; Costantino, J.; Panchal, R. G.; Hartley, J. L.; Aman, M. J.; Bavari, S.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S421-S429.
  1. 11.   HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood
  2. Pinto, L. A.; Castle, P. E.; Roden, R. B.; Harro, C. D.; Lowy, D. R.; Schiller, J. T.; Wallace, D.; Williams, M.; Kopp, W.; Frazer, I. H.; Berzofsky, J. A.; Hildesheim, A.
  3. Vaccine. 2005, MAY 20; 23(27): 3555-3564.
  1. 12.   Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
  2. Luo, K.; Liu, B. D.; Xiao, Z. X.; Yu, Y. K.; Yu, X. H.; Gorelick, R.; Yu, X. F.
  3. Journal of Virology. 2004, NOV; 78(21): 11841-11852.
  1. 13.   Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles
  2. Mossman, S. P.; Pierce, C. C.; Watson, A. J.; Robertson, M. N.; Montefiori, D. C.; Kuller, L.; Richardson, B. A.; Bradshaw, J. D.; Munn, R. J.; Hu, S. L.; Greenberg, P. D.; Benveniste, R. E.; Haigwood, N. L.
  3. Aids Research and Human Retroviruses. 2004 20(4): 425-434.
  1. 14.   Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release
  2. Heidecker, G.; Lloyd, P. A.; Fox, K.; Nagashima, K.; Derse, D.
  3. Journal of Virology. 2004 78(12): 6636-6648.
  1. 15.   The Rad27 (Fen-1) nuclease inhibits Ty1 mobility in Saccharomyces cerevisiae
  2. Sundararajan, A.; Lee, B. S.; Garfinkel, D. J.
  3. Genetics. 2003 163(1): 55-67.
  1. 16.   In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding
  2. Panchal, R. G.; Ruthel, G.; Kenny, T. A.; Kallstrom, G. H.; Lane, D.; Badie, S. S.; Li, L. M.; Bavari, S.; Aman, M. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2003 100(26): 15936-15941.
  1. 17.   Assembly of vault-like particles in insect cells expressing only the major vault protein
  2. Stephen, A. G.; Raval-Fernandes, S.; Huynh, T.; Torres, M.; Kickhoefer, V. A.; Rome, L. H.
  3. Journal of Biological Chemistry. 2001 276(26): 23217-23220.
  1. 18.   The Saccharomyces cerevisiae DNA recombination and repair functions of the RAD52 epistasis group inhibit Tyl transposition
  2. Rattray, A. J.; Shafer, B. K.; Garfinkel, D. J.
  3. Genetics. 2000 154(2): 543-556.
  1. 19.   HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates
  2. Strickler, H. D.; Kirk, G. D.; Figueroa, J. P.; Ward, E.; Braithwaite, A. R.; Escoffery, C.; Drummond, J.; Goebel, B.; Waters, D.; McClimens, R.; Manns, A.
  3. International Journal of Cancer. 1999 80(3): 339-344.
  1. 20.   Posttranslational Inhibition of Ty1 Retrotransposition By Nucleotide Excision Repair Transcription Factor Tfiih Subunits Ss12p and Rad3p
  2. Lee, B. S.; Lichtenstein, C. P.; Faiola, B.; Rinckel, L. A.; Wysock, W.; Curcio, M. J.; Garfinkel, D. J.
  3. Genetics. 1998 148(4): 1743-1761.
  1. 21.   Posttranslational Regulation of Ty1 Retrotransposition By Mitogen-Activated Protein Kinase Fus3
  2. Conte, D.; Barber, E.; Banerjee, M.; Garfinkel, D. J.; Curcio, M. J.
  3. Molecular and Cellular Biology. 1998 18(5): 2502-2513.
  1. 22.   Interlaboratory Agreement Among Results of Human Papillomavirus Type 16 Enzyme-Linked Immunosorbent Assays
  2. Strickler, H. D.; Hildesheim, A.; Viscidi, R. P.; Shah, K. V.; Goebel, B.; Drummond, J.; Waters, D.; Sun, Y. P.; Hubbert, N. L.; Wacholder, S.; Brinton, L. A.; Han, C. L.; Nasca, P. C.; McClimens, R.; Turk, K.; Devairakkam, V.; Leitman, S.; Martin, C.; Schiller, J. T.
  3. Journal of Clinical Microbiology. 1997 35(7): 1751-1756.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel